Imprivata Inc (IMPR): Thomas W. Brigiotta , SVP, WW Sales and Field Ops of Imprivata Inc sold 10,000 shares on Apr 15, 2016. The Insider selling transaction was reported by the company on Apr 19, 2016 to the Securities and Exchange Commission. The shares were sold at $12.80 per share for a total value of $128,074.45 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Mar 17, 2016, Thomas W. Brigiotta (SVP, WW Sales and Field Ops) sold 10,000 shares at $11.40 per share price.On Mar 4, 2016, Christopher A Shaw (SVP and General Manager) sold 1,000 shares at $11.62 per share price.Also, On Dec 28, 2015, Omar Hussain (President and CEO) sold 30,000 shares at $10.71 per share price.On Dec 3, 2015, Jeffrey Kalowski (Chief Financial Officer) sold 5,000 shares at $11.54 per share price.
Imprivata Inc (IMPR) witnessed a volatile trading activity on Monday Apr 18, 2016 and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $12.8 and reached the intraday high at $12.87. The bulls started the profit booking and pushed the shares to intraday low of $12.42. The trading session was marked by a volume range of 67,568 shares exchanging hands. The 52-week high of the shares is $21.63 and the 52-week low is $9. The market cap of the company stands at $322 M and there are 2,51,10,044 shares in public circulation.
Company has been under the radar of several Street Analysts.Imprivata Inc is Reiterated by Oppenheimer to Outperform while Lowering the Price Target of the company shares to $ 16 from a previous price target of $17 . The Rating was issued on Feb 17, 2016.
Currently the company Insiders own 64% of Imprivata Inc shares according to the proxy statements.In the past twelve weeks, the net percent change held by company insiders has changed by -0.55%.Institutional Investors own 56.03% of Imprivata Inc shares.During last six month period, the net percent change held by insiders has seen a change of -1.19%.
Imprivata Inc. is a provider of healthcare information technology) IT security solutions. The Company’s solutions provide authentication management access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products which consists of three offerings: authentication management enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).